Related Experiment Video

Updated: Jun 16, 2026

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
11:34

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target

Published on: May 10, 2022

Interaction of hepatitis B virus core protein with human GIPC1

Raimundas Razanskas1, Kestutis Sasnauskas

  • 1Institute of Biotechnology, Graiciuno 8, 02241, Vilnius, Lithuania. raimis@ibt.lt

Archives of Virology
|January 22, 2010
PubMed

Insights

Hepatitis B virus core protein (HBc) interacts with human protein GIPC1. This interaction, mediated by the PDZ domain, is crucial for virus propagation and pathogenicity.

Area of Science:

  • Hepatology
  • Virology
  • Molecular Biology

Background:

  • Hepatitis B virus (HBV) core protein (HBc) interactions with host proteins are largely unknown but critical for viral propagation and pathogenicity.
  • Understanding these interactions can reveal new therapeutic targets for HBV infection.

Purpose of the Study:

  • To identify host-cell proteins that interact with the hepatitis B virus core protein (HBc).
  • To characterize the interaction between HBc and its identified partners, focusing on the molecular mechanisms involved.

Main Methods:

  • Screening of a human liver cDNA library to identify HBc-interacting proteins.
  • Co-immunoprecipitation and domain mapping to confirm and characterize the interaction between HBc and GIPC1.
  • Site-directed mutagenesis to investigate the role of the PDZ-interacting motif in the HBc-GIPC1 interaction.

Main Results:

  • The human protein GIPC1 was identified as a strong interacting partner of HBc.
  • The PDZ (Postsynaptic density-95/Discs large/Zonula occludens-1) domain was identified as the key region mediating the interaction between HBc and GIPC1.
  • A putative C-terminal PDZ-interacting motif on HBc was found to be essential for its interaction with GIPC1.

Conclusions:

  • Hepatitis B virus core protein (HBc) interacts with the host protein GIPC1 via its PDZ domain.
  • This interaction is mediated by a C-terminal PDZ-interacting motif on HBc, suggesting a significant role in HBV lifecycle.
  • The identification of GIPC1 as an HBc-interacting protein opens new avenues for understanding HBV pathogenesis and developing antiviral strategies.

More Related Videos

Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle09:35

Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle

Published on: February 1, 2017

Modeling Hepatitis B Virus Infection in Non-Hepatic 293T-NE-3NRs Cells09:02

Modeling Hepatitis B Virus Infection in Non-Hepatic 293T-NE-3NRs Cells

Published on: June 5, 2020

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Inhibitors Of Virion Release01:25

Inhibitors Of Virion Release

Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
Inhibitors of Virion Maturation and Assembly01:19

Inhibitors of Virion Maturation and Assembly

As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...
Transcytosis of IgG01:15

Transcytosis of IgG

Transcytosis is the process in which molecules are internalized by endocytosis, transported across the cell, and released through exocytosis from the opposite end of the cell. Molecules such as insulin, immunoglobulins, and certain nutrients are transferred through the recycling endosomes by recycling and transcytosis.
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...